Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,274.73
+178.91
(+0.36%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
Ocular Therapeutix, Inc. (OCUL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.17
+0.30
(+5.11%)
At close: 04:00PM EDT
6.20
+0.03
(+0.49%)
After hours:
07:58PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
58,443
58,443
51,494
43,522
17,403
Cost of revenue
5,281
5,281
4,540
4,406
2,083
Gross profit
53,162
53,162
46,954
39,116
15,320
Operating expenses
Research development
61,055
61,055
53,462
50,083
28,694
Selling general and administrative
74,489
74,489
72,146
67,070
49,473
Total operating expenses
135,544
135,544
125,608
117,153
78,167
Operating income or loss
-82,382
-82,382
-78,654
-78,037
-62,847
Interest expense
11,338
11,338
7,022
6,671
6,768
Total other income/expenses net
9,001
9,001
13,840
78,122
-86,189
Income before tax
-80,736
-80,736
-71,038
-6,553
-155,636
Income from continuing operations
-80,736
-80,736
-71,038
-6,553
-155,636
Net income
-80,736
-80,736
-71,038
-6,553
-155,636
Net income available to common shareholders
-80,736
-80,736
-71,038
-6,553
-155,636
Basic EPS
-0.86
-
-0.92
-0.09
-2.56
Diluted EPS
-1.01
-
-0.97
-0.98
-2.56
Basic average shares
77,960
-
76,875
76,393
60,752
Diluted average shares
83,729
-
82,644
82,162
60,752
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.